Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0370
-0.0010 (-2.63%)
Mar 18, 2026, 10:49 AM AEST
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 29.98 million as of March 18, 2026. Its market cap has increased by 160.54% in one year.
Market Cap
29.98M
Enterprise Value
26.97M
Revenue
3.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 29.98M, a decrease of -86.30%. That is a compound annual growth rate of -28.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 30.79M | 5.56% |
| Dec 31, 2025 | 29.17M | 140.15% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compumedics | 60.93M |
| HeraMED | 49.12M |
| Micro-X | 47.20M |
| Nova Eye Medical | 42.73M |
| CleanSpace Holdings | 37.48M |
| ImpediMed | 32.62M |
| CurveBeam AI | 29.14M |
| Control Bionics | 22.66M |